AKT2 and diabetic kidney disease: Gödel et al indicated that mTORC2 was essential for podocyte development and maintenance in diabetic nephropathy [32], and Canaud et al found that AKT2 activation by mTORC2 was required for podocyte survival in nephron reduction-induced renal disease [33].